Skip to main content

Advertisement

Table 1 Patient characteristics

From: Efficacy of triple antiemetic therapy (palonosetron, dexamethasone, aprepitant) for chemotherapy-induced nausea and vomiting in patients receiving carboplatin-based, moderately emetogenic chemotherapy

Sex Male/female 72/18
Type of malignancy Small-cell lung cancer 10
Non-small-cell lung cancer 80
Performance status 0 35
1 50
2 5
Median age (range), years   69 (38–82)
Chemotherapy regimen   
  Carboplatin + paclitaxel 35
  Carboplatin + pemetrexed 24
  Carboplatin + TS-1 13
  Carboplatin + etoposide 12
  Carboplatin + docetaxel 6